Psychiatry Research: Neuroimaging
Volume 174, Issue 2 , Pages 130-137, 30 November 2009

The effects of lorazepam on extrastriatal dopamine D2/3-receptors—A double-blind randomized placebo-controlled PET study

  • Harry Vilkman

      Affiliations

    • Turku PET Centre, University of Turku, Turku, Finland
  • ,
  • Jaana Kajander

      Affiliations

    • Turku PET Centre, University of Turku, Turku, Finland
  • ,
  • Sargo Aalto

      Affiliations

    • Turku PET Centre, University of Turku, Turku, Finland
    • Department of Psychology, Åbo Akademi University, Turku, Finland
  • ,
  • Tero Vahlberg

      Affiliations

    • Institute of Clinical Medicine, Biostatistics, University of Turku, Turku, Finland
  • ,
  • Kjell Någren

      Affiliations

    • Turku PET Centre, Radiopharmaceutical Chemistry Laboratory, Turku, Finland
  • ,
  • Topias Allonen

      Affiliations

    • Turku PET Centre, University of Turku, Turku, Finland
  • ,
  • Erkka Syvälahti

      Affiliations

    • Department of Pharmacology and Clinical Pharmacology, University of Turku, Turku, Finland
  • ,
  • Jarmo Hietala

      Affiliations

    • Turku PET Centre, University of Turku, Turku, Finland
    • Department of Psychiatry, University of Turku, Kunnallissairaalantie 20, Building 9, 20700 Turku, Finland
    • Corresponding Author InformationCorresponding author. Department of Psychiatry, University of Turku, Kunnallissairaalantie 20, Building 9, 20700 Turku, Finland. Tel.: +358 2 269 2520; fax: +358 2 269 2528.

Received 6 December 2007; received in revised form 19 April 2009; accepted 19 April 2009.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 The data were presented in abstract form in the 19th ECNP Congress, Paris, France, 16-20 September 2006 (European Neuropsychopharmacology, Volume 16, Supplement 4, page S266).

PII: S0925-4927(09)00110-3

doi:10.1016/j.pscychresns.2009.04.006

Psychiatry Research: Neuroimaging
Volume 174, Issue 2 , Pages 130-137, 30 November 2009